Skip to main content
Signal8

Poetting Sierk

SEC insider (Form 3/4/5 filer). CIK 0001955589. Chief Operating Officer at BioNTech SE (BNTX). 3 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in MAINZ.

Companies Poetting Sierk has filed insider reports for

  • BioNTech SE (BNTX): Officer, Chief Operating Officer
Poetting Sierk profile photo

Poetting Sierk

CIK: 0001955589

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BioNTech SE logo
BNTX

BioNTech SE

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • BioNTech SE logo
    BNTX

    BioNTech SE

    May 12, 2026
    Award

    Option (right to buy)

    Direct
    12.6K shares-
  • BioNTech SE logo
    BNTX

    BioNTech SE

    May 12, 2026
    Award

    Performance Share Unit

    Direct
    10.1K shares-
  • BioNTech SE logo
    BNTX

    BioNTech SE

    Apr 22, 2026
    Sale
    Indirect
    50K shares at avg. $110.56$5.5M

1-3 of 3